JPH11508265A - 抗生物質抵抗性グラム陽性細菌の制御および感染治療の方法 - Google Patents
抗生物質抵抗性グラム陽性細菌の制御および感染治療の方法Info
- Publication number
- JPH11508265A JPH11508265A JP9503995A JP50399597A JPH11508265A JP H11508265 A JPH11508265 A JP H11508265A JP 9503995 A JP9503995 A JP 9503995A JP 50399597 A JP50399597 A JP 50399597A JP H11508265 A JPH11508265 A JP H11508265A
- Authority
- JP
- Japan
- Prior art keywords
- herring
- resistant
- antibiotic
- treatment
- vancomycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.ヒトおよび動物において疾患の原因となる抗生物質抵抗性病原細菌を殺傷す る方法において、最小阻害濃度よりも過剰量のラントシン抗菌剤を投与すること を特徴とする方法。 2.ラントシンは、ニシン、サブチリン、エピダ−ミン、ガリダ−ミン、ペップ 5、シナマイシン、ドゥラマイシン、およびアンコベニンからなるグル−プから 選択されることを特徴とする請求の範囲第1項記載の方法。 3.ラントシンはニシンであることを特徴とする請求の範囲第2項記載の方法。 4.ラントシンは、部位特異的突然変異法により生成された構造的変異体あるい は半合成アナログであることを特徴とする請求の範囲第1項に記載の方法。 5.病原細菌は、スタヒロコッカス、ストレプトコッカス、およびエンテロコッ カスから選択される属の抗生物質抵抗性単離株であることを特徴とする請求の範 囲第1項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43595P | 1995-06-23 | 1995-06-23 | |
US60/000,435 | 1995-06-23 | ||
PCT/US1996/010756 WO1997000694A1 (en) | 1995-06-23 | 1996-06-21 | A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11508265A true JPH11508265A (ja) | 1999-07-21 |
JP4236699B2 JP4236699B2 (ja) | 2009-03-11 |
Family
ID=21691527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50399597A Expired - Fee Related JP4236699B2 (ja) | 1995-06-23 | 1996-06-21 | 抗生物質抵抗性グラム陽性細菌の制御および感染治療の方法 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5866539A (ja) |
EP (1) | EP0833657B1 (ja) |
JP (1) | JP4236699B2 (ja) |
KR (1) | KR19990028283A (ja) |
CN (1) | CN1138560C (ja) |
AT (1) | ATE247973T1 (ja) |
AU (1) | AU713050B2 (ja) |
BR (1) | BR9609281A (ja) |
CA (1) | CA2225530C (ja) |
CZ (1) | CZ290578B6 (ja) |
DE (1) | DE69629691T2 (ja) |
ES (1) | ES2201189T3 (ja) |
IL (2) | IL122248A0 (ja) |
NO (1) | NO976028D0 (ja) |
NZ (1) | NZ311535A (ja) |
RU (1) | RU2202360C2 (ja) |
SK (1) | SK285563B6 (ja) |
WO (1) | WO1997000694A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697639B2 (en) | 2005-07-28 | 2014-04-15 | Biosynexus Incorporated | Compositions and methods for treating bacteria |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910479A (en) * | 1996-10-18 | 1999-06-08 | Ambi Inc. | Method for the treatment of Streptococcus pneumoniae infection |
US5985823A (en) * | 1997-06-09 | 1999-11-16 | Ambi Inc. | Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
EP1212006B1 (en) * | 1999-08-31 | 2006-02-22 | Gore Enterprise Holdings, Inc. | Improved dental floss having low density |
NL1013861C2 (nl) * | 1999-12-15 | 2001-06-18 | Stichting Tech Wetenschapp | Toepassing van Nisine of derivaat daarvan. |
US6403652B1 (en) | 2000-06-30 | 2002-06-11 | Colgate-Palmolive Company | Method and composition |
AU2003296937A1 (en) * | 2002-12-10 | 2004-06-30 | Biosynexus Incorporated | Topical anti-infective formulations |
US7576054B2 (en) * | 2005-10-11 | 2009-08-18 | Biosynexus Incorporated | Compositions and methods for treating bacteria |
GB0600928D0 (en) | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
WO2007092582A2 (en) * | 2006-02-08 | 2007-08-16 | Biosynexus Incorporated | Neutralization of bacterial spores |
ITMI20060678A1 (it) * | 2006-04-06 | 2007-10-07 | Sanofi Aventis Otc S P A | Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni |
GB0714029D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
GB0714030D0 (en) * | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
RU2506272C2 (ru) * | 2008-11-24 | 2014-02-10 | Сентинелла Фармасьютикалз, Инк. ("Сентинелла") | Лантибиотические карбоксиамидные производные с усиленной антибактериальной активностью |
KR101107764B1 (ko) * | 2009-01-05 | 2012-01-20 | 박세준 | 항 유해균 기능을 가진 에스제이피미생물 |
EP2387580B1 (en) | 2009-01-14 | 2014-08-13 | Novacta Biosystems Limited | Deoxyactagardine derivatives |
JP5731407B2 (ja) | 2009-02-04 | 2015-06-10 | ノヴァクタ バイオシステムズ リミティッド | アクタガルジン誘導体 |
EP2405742A2 (en) * | 2009-03-11 | 2012-01-18 | CryoLife, Inc. | Bioburden-reducing antibiotic composition and method of use |
GB201001688D0 (en) | 2010-02-02 | 2010-03-17 | Novacta Biosystems Ltd | Compounds |
US8475827B2 (en) | 2010-07-06 | 2013-07-02 | Cryolife, Inc. | Tissue implants for implantation and methods for preparing the same |
US8377143B2 (en) | 2010-07-06 | 2013-02-19 | Cryolife, Inc. | Tissue implants for implantation and methods for preparing the same |
GB201013513D0 (en) | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Formulations |
US8182842B1 (en) | 2010-11-10 | 2012-05-22 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria |
RU2638814C1 (ru) * | 2016-09-27 | 2017-12-15 | Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации | Способ профилактики инфекционных осложнений бактериальной природы после операции на сердце, проведенной в условиях искусственного кровообращения |
CN108982430B (zh) * | 2017-05-31 | 2020-09-29 | 北京大学 | 标记细菌菌群样品的试剂盒、方法及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4931390A (en) * | 1986-04-16 | 1990-06-05 | Public Health Research Institute Of The City Of New York, Inc. | Expression of the cloned lysostaphin gene |
US5260271A (en) * | 1988-06-22 | 1993-11-09 | Applied Microbiology, Inc. | Nisin compositions for use as enhanced broad range bactericides |
US5217950A (en) * | 1988-06-22 | 1993-06-08 | Applied Microbiology, Inc. | Nisin compositions for use as enhanced, broad range bactericides |
US5334582A (en) * | 1988-06-22 | 1994-08-02 | Applied Microbiology, Inc. | Pharmaceutical bacteriocin compositions and methods for using the same |
US4980163A (en) * | 1989-03-01 | 1990-12-25 | Public Health Research Institute Of The City Of New York | Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
US5512269A (en) * | 1993-06-09 | 1996-04-30 | Burroughs Wellcome, Co. | Method of treating retained pulmonary secretions |
-
1996
- 1996-06-21 NZ NZ311535A patent/NZ311535A/en not_active IP Right Cessation
- 1996-06-21 SK SK1726-97A patent/SK285563B6/sk not_active IP Right Cessation
- 1996-06-21 JP JP50399597A patent/JP4236699B2/ja not_active Expired - Fee Related
- 1996-06-21 KR KR1019970709597A patent/KR19990028283A/ko not_active Application Discontinuation
- 1996-06-21 AU AU62891/96A patent/AU713050B2/en not_active Ceased
- 1996-06-21 CA CA002225530A patent/CA2225530C/en not_active Expired - Fee Related
- 1996-06-21 CZ CZ19974025A patent/CZ290578B6/cs not_active IP Right Cessation
- 1996-06-21 WO PCT/US1996/010756 patent/WO1997000694A1/en not_active Application Discontinuation
- 1996-06-21 ES ES96921757T patent/ES2201189T3/es not_active Expired - Lifetime
- 1996-06-21 CN CNB961949406A patent/CN1138560C/zh not_active Expired - Fee Related
- 1996-06-21 US US08/667,650 patent/US5866539A/en not_active Expired - Lifetime
- 1996-06-21 DE DE69629691T patent/DE69629691T2/de not_active Expired - Lifetime
- 1996-06-21 RU RU97121577/14A patent/RU2202360C2/ru not_active IP Right Cessation
- 1996-06-21 EP EP96921757A patent/EP0833657B1/en not_active Expired - Lifetime
- 1996-06-21 IL IL12224896A patent/IL122248A0/xx unknown
- 1996-06-21 BR BR9609281A patent/BR9609281A/pt unknown
- 1996-06-21 AT AT96921757T patent/ATE247973T1/de not_active IP Right Cessation
-
1997
- 1997-11-19 IL IL122248A patent/IL122248A/en not_active IP Right Cessation
- 1997-12-22 NO NO976028A patent/NO976028D0/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697639B2 (en) | 2005-07-28 | 2014-04-15 | Biosynexus Incorporated | Compositions and methods for treating bacteria |
Also Published As
Publication number | Publication date |
---|---|
NZ311535A (en) | 2001-05-25 |
AU6289196A (en) | 1997-01-22 |
JP4236699B2 (ja) | 2009-03-11 |
WO1997000694A1 (en) | 1997-01-09 |
KR19990028283A (ko) | 1999-04-15 |
EP0833657B1 (en) | 2003-08-27 |
CN1138560C (zh) | 2004-02-18 |
AU713050B2 (en) | 1999-11-25 |
RU2202360C2 (ru) | 2003-04-20 |
IL122248A0 (en) | 1998-04-05 |
NO976028L (no) | 1997-12-22 |
US5866539A (en) | 1999-02-02 |
ATE247973T1 (de) | 2003-09-15 |
DE69629691T2 (de) | 2004-02-26 |
CZ290578B6 (cs) | 2002-08-14 |
NO976028D0 (no) | 1997-12-22 |
IL122248A (en) | 2009-09-01 |
CZ402597A3 (cs) | 1998-09-16 |
SK285563B6 (sk) | 2007-03-01 |
SK172697A3 (en) | 1998-12-02 |
BR9609281A (pt) | 1999-06-15 |
CA2225530A1 (en) | 1997-01-09 |
CA2225530C (en) | 2002-08-20 |
CN1188415A (zh) | 1998-07-22 |
EP0833657A1 (en) | 1998-04-08 |
ES2201189T3 (es) | 2004-03-16 |
DE69629691D1 (de) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4236699B2 (ja) | 抗生物質抵抗性グラム陽性細菌の制御および感染治療の方法 | |
Hof et al. | Management of listeriosis | |
JP5140579B2 (ja) | 病原菌に対する生体防御を増強するヒアルロン酸結合性ペプチド | |
Mader et al. | Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits | |
JPH09508359A (ja) | 抗グラム陽性細菌学的方法および物質 | |
KR20010022237A (ko) | 리소스타핀을 단독 또는 항생제와의 조합으로 포함하는포도상구균 감염 치료용 약제학적 조성물 | |
Caron et al. | Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin-and highly glycopeptideresistant isolate of enterococcus faecium | |
Chambers | In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a | |
Yamaoka | The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytized MRSA | |
US6565854B2 (en) | Antimicrobial histone H1 compositions, kits, and methods of use thereof | |
Biedenbach et al. | The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci | |
Brauers et al. | Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations | |
Berry et al. | Imipenem therapy of experimental Staphylococcus epidermidis endocarditis | |
US20220160842A1 (en) | Method of treating infective endocarditis | |
US5910479A (en) | Method for the treatment of Streptococcus pneumoniae infection | |
US20240041976A1 (en) | Composition and use | |
Al-Nawas et al. | In vitro activity of LY333328, a new glycopeptide, against extracellular and intracellular vancomycin-resistant enterococci | |
CN114432428A (zh) | PGLa提高细菌对抗生素的敏感性和延缓细菌耐药性产生的应用 | |
CZ20011014A3 (cs) | Farmaceutické přípravky obsahující lipoproteinová antibiotika |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060919 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061218 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070320 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070619 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070919 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071003 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071029 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080805 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081008 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20081125 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20081217 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111226 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |